共 45 条
[2]
Chaplin DJ, 2006, CURR OPIN INVEST DR, V7, P522
[3]
Chawla R, 2010, ACTA POL PHARM, V67, P247
[6]
GRIGGS J, 2001, LANCET ONCOL, V2, P81
[7]
Groziak MP, 2000, PROG HET CH, V12, P1, DOI 10.1016/S0959-6380(00)80003-3
[8]
Haar E.T., 1996, BIOORGAN MED CHEM, V4, P1659
[10]
Vascular disrupting agents in clinical development
[J].
BRITISH JOURNAL OF CANCER,
2007, 96 (08)
:1159-1165